Guide RNA (gRNA) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

guide RNA (gRNA) Market – Report Overview

Pacific Business Consulting’s “guide RNA (gRNA) Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of guide RNA (gRNA) market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the guide RNA (gRNA) market exceeded a valuation of over US$ 550.0 million, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 12.0% from 2023 to 2030. The market is expected to potentially surpass US$ 900.0 million by 2030.

gRNA technology has demonstrated its potential in two key domains, contributing to the creation of swift CRISPR-based COVID-19 tests and the exploration of CRISPR-based antiviral therapies. The global pandemic heightened public awareness and interest in gene-editing tools like CRISPR-Cas9, leading to increased recognition of gRNA’s capabilities and fostering greater market awareness. The varied responses of individuals to the virus underscored the significance of personalized medicine.

The expanding research and development (R&D) activities in proteomics and genomics serve as pivotal drivers for the market. Genomics R&D endeavors focus on identifying and validating potential therapeutic targets and unraveling gene functions. gRNAs play a crucial role in this context, facilitating precise gene editing using CRISPR/Cas systems. Researchers leverage gRNAs to modify genes of interest, enabling the study of their effects and aiding in the identification and validation of key targets. Large-scale proteomics and genomics studies often require gRNAs for functional genomics research, allowing for the selective modulation or knockout of specific genes. This capability aids in comprehending gene function and deciphering intricate biological pathways.

Governments and private organizations are making substantial investments in proteomics and genomics research, leading to a surge in demand for gRNA technology. Notably, in April 2021, the U.S. government allocated US$ 1.7 billion in funding to support and expand genomic sequencing technologies. The high demand for gRNA arises from its pivotal role in CRISPR-based genetic editing. Its unique ability to guide the CRISPR system to specific DNA sequences makes it an indispensable tool in precision gene editing. Researchers and scientists depend on gRNA to precisely target and modify genes, fostering groundbreaking advancements in medicine, agriculture, and biotechnology. The versatility, accuracy, and efficiency of gRNA have fueled its demand, promising potential cures for genetic disorders, innovative agricultural practices, and the exploration of fundamental biological processes. As the pursuit of targeted genetic modifications intensifies, gRNA remains a sought-after component driving genetic research.

Leading players in the guide RNA (gRNA) segment, including Takara Bio Inc., Synbio Technologies, Revvity Inc (Horizon Discovery Ltd.), Synthego, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., System Biosciences; LLC., Jena Bioscience GmbH, Merck KGaA, Azenta Life Sciences (Genewiz), are expected to play a crucial role in shaping the future landscape of guide RNA (gRNA) technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the guide RNA (gRNA) market. It also delves into the analysis of present and prospective market competition within the global guide RNA (gRNA) market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the guide RNA (gRNA) market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM guide RNA (gRNA) market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: guide RNA (gRNA)
   • Global Market Outlook: guide RNA (gRNA)
2. Competitive Intelligence Analysis: guide RNA (gRNA)
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: guide RNA (gRNA)
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: guide RNA (gRNA)
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. guide RNA (gRNA): Ten Major Market (10MM) – Market Analysis, By Product
   • gRNA Final Products
   • gRNA Synthesis Products
   • gRNA Synthesis Services
9. guide RNA (gRNA): Ten Major Market (10MM) – Market Analysis, By Application
   • Disease Model Studies
   • Epigenetics
   • Genome Engineering
   • Functional Genomics
   • Others
10. guide RNA (gRNA): Ten Major Market (10MM) – Market Analysis, By End User
    • Pharmaceutical & Biotechnology Companies
    • CMOs & CROs
    • Academic and Research Institutes
11. guide RNA (gRNA): Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

12. S. guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

13. K. guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

14. Germany guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

15. France guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

16. Italy guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

17. Spain guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

18. Japan guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

19. China guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

20. Australia guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

21. India guide RNA (gRNA) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer